COMPASS Pathways Market Cap

COMPASS Pathways has a market cap or net worth of $538.20 million as of May 17, 2024. Its market cap has increased by 38.46% in one year.

Market Cap

538.20M

Enterprise Value

307.73M

1-Year Change

38.46%

Ranking

#2931

Market Cap Chart

Since the IPO on September 18, 2020, COMPASS Pathways's market cap has decreased from $568.58M to $538.20M, a decrease of -5.34%. That is a compound annual growth rate of -1.49%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	536.10M	-1.89%
May 16, 2024	546.40M	-3.50%
May 15, 2024	566.20M	1.34%
May 14, 2024	558.70M	0.61%
May 13, 2024	555.30M	3.31%
May 10, 2024	537.50M	-7.96%
May 9, 2024	584.00M	0.48%
May 8, 2024	581.20M	5.96%
May 7, 2024	548.50M	-0.81%
May 6, 2024	553.00M	0.93%
May 3, 2024	547.90M	3.40%
May 2, 2024	529.90M	-2.70%
May 1, 2024	544.60M	-1.05%
Apr 30, 2024	550.40M	5.66%
Apr 29, 2024	520.90M	2.14%
Apr 26, 2024	510.00M	1.03%
Apr 25, 2024	504.80M	-2.96%
Apr 24, 2024	520.20M	-1.83%
Apr 23, 2024	529.90M	-1.30%
Apr 22, 2024	536.90M	-0.24%
Apr 19, 2024	538.20M	-0.48%
Apr 18, 2024	540.80M	-1.30%
Apr 17, 2024	547.90M	-2.84%
Apr 16, 2024	563.90M	5.52%
Apr 15, 2024	534.40M	-3.92%

View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Third Harmonic Bio	561.22M
Pacific Biosciences of California	552.88M
Olema Pharmaceuticals	551.23M
IGM Biosciences	541.25M
SIGA Technologies	541.24M
Adaptive Biotechnologies	532.00M
IRadimed	530.88M
Astria Therapeutics	525.52M

Market Cap Rankings